EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.98 | MS-275 | - |
Homo sapiens | |
3.5.1.98 | scriptaid | - |
Homo sapiens | |
3.5.1.98 | suberoylanilide hydroxamic acid | - |
Homo sapiens | |
3.5.1.98 | trichostatin A | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.98 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.1.98 | airway epithelial cell | - |
Homo sapiens | - |
3.5.1.98 | primary cell | - |
Homo sapiens | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.98 | HDAC7 | - |
Homo sapiens |
3.5.1.98 | histone deacetylase 7 | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.5.1.98 | malfunction | HDAC inhibition improves DELTAF508 cystic fibrosis transmembrane conductance regulator stability and trafficking, silencing of HDAC2 and HDAC3 causes a 2.5fold and 1.5fold increase in DELTAF508 cystic fibrosis transmembrane conductance regulator mRNA, respectively, as well as an about 5fold increase in total DELTAF508 protein. Silencing of HDAC1 induces a 1.4fold stimulation of iodide efflux. In contrast, silencing of HDAC7 exhibits a 3.6fold stimulation of cAMP-mediated iodide efflux comparable to 30°C efflux | Homo sapiens |
3.5.1.98 | physiological function | HDAC7 plays a central role in restoration of DELTAF508 cystic fibrosis transmembrane conductance regulator function | Homo sapiens |